(Q39196262)

9 September 2017

Seroepidemiology of hepatitis A and hepatitis E viruses in Aden, Yemen (English)

1 reference

9 September 2017

0 references

1 reference

1 reference

6

1 reference

9 September 2017

Amen Ahmed Bawazir

1

0 references

Nick J. Beeching

object named as

Nicholas J Beeching

5

0 references

author name string

C Anthony Hart

2

1 reference

9 September 2017

Tallal A Sallam

3

1 reference

9 September 2017

Christopher M Parry

4

1 reference

9 September 2017

9 September 2010

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

9 September 2017

1 reference

9 September 2017

104

1 reference

9 September 2017

12

1 reference

9 September 2017

801-805

1 reference

Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response.

9 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2010.08.007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2010.08.007

Epidemiology and clinical features of sporadic hepatitis E as compared with hepatitis A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2010.08.007

Consumption of wild boar linked to cases of hepatitis E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2010.08.007

Evaluation of diagnostic assays for hepatitis E virus in outbreak settings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2010.08.007

Declining hepatitis A seroprevalence: a global review and analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2010.08.007

Shifting seroepidemiology of hepatitis A in Japan, 1973-2003.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2010.08.007

Hepatitis a in Lebanon: a changing epidemiological pattern

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2010.08.007

Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2010.08.007

Hepatitis E vaccine--ready for prime time?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2010.08.007

A seroepidemiological survey of viral hepatitis in the Yemen Arab Republic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2010.08.007

Acute sporadic hepatitis in the Republic of Yemen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2010.08.007

Seroepidemiology of hepatitis A virus infection among school children in Delhi and north Indian patients with chronic liver disease: implications for HAV vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2010.08.007

Hepatitis A shifting epidemiology in the Middle East and Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2010.08.007

Hepatitis E virus: an update on its molecular, clinical and epidemiological characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2010.08.007

Sero-prevalence and mother-to-infant transmission of hepatitis E virus among pregnant women in the United Arab Emirates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2010.08.007

Hepatitis E antibody seroconversion without disease in highly endemic rural Egyptian communities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2010.08.007

Epidemiology of hepatitis E virus in male blood donors in Jeddah, Saudi Arabia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2010.08.007

10.1016/J.TRSTMH.2010.08.007

7 January 2021

Identifiers

DOI

1 reference

release_2vll53innfcbtnmnsuvmo4wwpa

9 September 2017

0 references

1 reference